Xiangling H. He
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study.
Journal: Annals of hematology
Published: December 29, 2025
Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia.
Journal: Cancer medicine
Published: September 17, 2025
Pediatric NUT carcinoma: a patient series and literature review.
Journal: BMC pediatrics
Published: March 31, 2025
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.
Journal: Frontiers in pharmacology
Published: April 18, 2024
Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study.
Journal: Cancer research and treatment
Published: January 30, 2024
Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational study.
Journal: Journal of cancer research and clinical oncology
Published: November 16, 2023
RT-PCR demonstrates superior sensitivity and specificity in detecting the five neuroblastoma genes compared to the flow cytometry method for measurable residual disease.
Journal: Translational pediatrics
Published: November 07, 2023
HAND2-AS1 plays a tumor-suppressive role in hepatoblastoma through the negative regulation of CDK1.
Journal: Heliyon
Published: June 15, 2023
Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia.
Journal: BMC cancer
Published: May 09, 2023
Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance.
Journal: Frontiers in pediatrics
Published: March 18, 2023
Allogeneic hematopoietic stem cell transplantation corrects ligase IV deficiency.
Journal: Transplant immunology
Published: December 03, 2022
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysis.
Journal: Cancer medicine
Published: November 16, 2022
Last Updated: 09/26/2026